The global intraoperative imaging market was valued at $2,039.1 million in 2021, and is projected to reach $3,790.7 million by 2031, registering a CAGR of 6.5% from 2022 to 2031.
Intraoperative imaging in an optical imaging technology that is used by surgeons in different types of surgical procedures such as neurosurgeries, orthopedic surgeries, cardiovascular surgeries, and gastrointestinal surgeries. It is especially used in cancer surgeries for removal of tumor. The system is further applicable in minimally invasive surgical procedures. Intraoperative imaging system allows surgeons to visualize the anatomy of the patient. This system provides in-depth images of surgical areas with its highly specialized cameras and display system. This device finds it application in different type of surgeries Intraoperative ultrasound, intraoperative computed tomography (iCT), intraoperative medical resonance imaging (iMRI), intraoperative X-ray, and mobile C-arm are the types of intraoperative imaging.
The growth of the intraoperative imaging market is majorly driven by increase in the number of surgical procedures as well as rise in prevalence of chronic disorders such as cancer, orthopedic diseases, neurology diseases, trauma cases, and cardiovascular disease. Moreover, rise in efforts of key players to launch intraoperative imaging devices propels the growth of the intraoperative imaging market. Moreover, increase in number of surgeries such as neurosurgery, orthopedic & trauma surgeries, spine surgeries, ear-nose-throat surgeries, and gastroenterology surgeries escalates the need for intraoperative imaging devices, thus driving the market growth. For instance, orthopedic surgeries such as knee and hip replacement surgery uses intraoperative imaging to get in-depth images of surgical sites.
In Canada, knee and hip replacement surgery is the second most common surgery. As per the report published by the Canadian Joint Replacement Registry (CJRR), approximately more than 75,000 knee replacement and 63,000 hip replacement surgeries were performed in the Canada from 2019 to 2020. This report further states 2.4% increase in the hip replacement surgery from 2019 to 2020.
Brain tumor is one of leading disorders, which needs intraoperative imaging device to perform brain tumor surgery. Thus, increase in number of brain tumor disorders leads to rise in use of intraoperative imaging device, which propels the growth of the global market. According to the American Society of Clinical Oncology (ASCO) report, in February 2022, around 25,050 adults in which 14,170 men and 10,880 women were diagnosed with brain and spinal cord tumor in the U.S.
In addition, upsurge in geriatric population fuels the growth of intraoperative imaging market. This is attributed to the fact that aged individuals are highly susceptible to chronic disorders, which further increases the number of surgeries to treat those disorders. This eventually boosts the use of intraoperative imaging devices, thereby fostering the growth of the intraoperative imaging market. Furthermore, upsurge in minimally invasive surgical procedures acts as a key driving force of the market.
The global intraoperative imaging market is segmented into type and region. Depending on type, the market is categorized into intraoperative ultrasound, intraoperative CT, intraoperative MRI, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Some of the major companies that operate in the global intraoperative imaging market are Brainlab AG, Carestream Health, Carl Zeiss Meditec AG, Fujifilm Holding, General Electric Company, Koninklijke Philips N.V., Medtronic, Siemens Healthineers AG, Stryker, and Ziehm Imaging GmbH.
Intraoperative imaging in an optical imaging technology that is used by surgeons in different types of surgical procedures such as neurosurgeries, orthopedic surgeries, cardiovascular surgeries, and gastrointestinal surgeries. It is especially used in cancer surgeries for removal of tumor. The system is further applicable in minimally invasive surgical procedures. Intraoperative imaging system allows surgeons to visualize the anatomy of the patient. This system provides in-depth images of surgical areas with its highly specialized cameras and display system. This device finds it application in different type of surgeries Intraoperative ultrasound, intraoperative computed tomography (iCT), intraoperative medical resonance imaging (iMRI), intraoperative X-ray, and mobile C-arm are the types of intraoperative imaging.
The growth of the intraoperative imaging market is majorly driven by increase in the number of surgical procedures as well as rise in prevalence of chronic disorders such as cancer, orthopedic diseases, neurology diseases, trauma cases, and cardiovascular disease. Moreover, rise in efforts of key players to launch intraoperative imaging devices propels the growth of the intraoperative imaging market. Moreover, increase in number of surgeries such as neurosurgery, orthopedic & trauma surgeries, spine surgeries, ear-nose-throat surgeries, and gastroenterology surgeries escalates the need for intraoperative imaging devices, thus driving the market growth. For instance, orthopedic surgeries such as knee and hip replacement surgery uses intraoperative imaging to get in-depth images of surgical sites.
In Canada, knee and hip replacement surgery is the second most common surgery. As per the report published by the Canadian Joint Replacement Registry (CJRR), approximately more than 75,000 knee replacement and 63,000 hip replacement surgeries were performed in the Canada from 2019 to 2020. This report further states 2.4% increase in the hip replacement surgery from 2019 to 2020.
Brain tumor is one of leading disorders, which needs intraoperative imaging device to perform brain tumor surgery. Thus, increase in number of brain tumor disorders leads to rise in use of intraoperative imaging device, which propels the growth of the global market. According to the American Society of Clinical Oncology (ASCO) report, in February 2022, around 25,050 adults in which 14,170 men and 10,880 women were diagnosed with brain and spinal cord tumor in the U.S.
In addition, upsurge in geriatric population fuels the growth of intraoperative imaging market. This is attributed to the fact that aged individuals are highly susceptible to chronic disorders, which further increases the number of surgeries to treat those disorders. This eventually boosts the use of intraoperative imaging devices, thereby fostering the growth of the intraoperative imaging market. Furthermore, upsurge in minimally invasive surgical procedures acts as a key driving force of the market.
The global intraoperative imaging market is segmented into type and region. Depending on type, the market is categorized into intraoperative ultrasound, intraoperative CT, intraoperative MRI, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Some of the major companies that operate in the global intraoperative imaging market are Brainlab AG, Carestream Health, Carl Zeiss Meditec AG, Fujifilm Holding, General Electric Company, Koninklijke Philips N.V., Medtronic, Siemens Healthineers AG, Stryker, and Ziehm Imaging GmbH.
KEY BENEFITS FOR STAKEHOLDERS
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the intraoperative imaging market analysis from 2021 to 2031 to identify the prevailing intraoperative imaging market opportunity.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the intraoperative imaging market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global intraoperative imaging market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Type
- Intraoperative Ultrasound
- Intraoperative CT
- Intraoperative MRI
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- General Electric Company
- Medtronic, Inc.
- Koninklijke Philips N.V.
- Siemens Healthineers AG
- Stryker Corporation
- Fujifilm Holdings
- carestream health
- carl zeiss meditec ag
- Brainlab AG
- Ziehm Imaging GmbH
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: INTRAOPERATIVE IMAGING MARKET, BY TYPE
CHAPTER 5: INTRAOPERATIVE IMAGING MARKET, BY REGION
CHAPTER 6: COMPANY LANDSCAPE
CHAPTER 7: COMPANY PROFILES
List of Tables
List of Figures
Executive Summary
According to the report, titled, “Intraoperative Imaging Market," the intraoperative imaging market size was valued at $2.0 billion in 2021, and is estimated to reach $3.8 billion by 2031, growing at a CAGR of 6.5% from 2022 to 2031.Intraoperative phase is defined as the phase of surgery, which is considered from the admission of patient into operation theatre to completion of surgical procedure. This technology is gaining high traction in the market as a critical tool for precise and effective surgeries. It helps to improve surgical outcome and enhances the workflow and efficiencies for healthcare personnel.
An intraoperative imaging system creates images of particular surgical site and these images guide the surgeon to perform the surgery. It further enables the surgeons to get the image of implants they place into the patient’s body, which guides the surgeon to place it correctly.
Factors that drive growth of the global intraoperative imaging market share are increase in prevalence of chronic diseases such as cancer, orthopedic diseases, neurology diseases, and heart disease; increase in the number of surgical procedures such as neurosurgery, orthopedic & trauma care, spine surgery, cardiovascular surgeries, and gastroenterology; and rise in efforts of intraoperative imaging industry to launch advanced intraoperative imaging devices. Moreover, surge in number of minimally invasive surgeries, which is highly dependent on the imaging system fuels the intraoperative imaging market growth. In addition, rise in geriatric population is anticipated to propel the intraoperative imaging market trends. This is attributed to the fact that aged individuals are highly vulnerable to chronic diseases, which leads to increase in number of surgical procedures. For instance, according to the World Health Organization (WHO), in October 2021, 1 in 6 individuals in the world will be aged 60 years or over, by 2030.
Moreover, according to the Journal of JAMA Network Open, in 2021, about 32% of surgical procedure in the U.S. were reported to have conducted in patients aged more than 65 years. Thus, increase in number of surgical procedure further surges the need for intraoperative devices. The global intraoperative imaging market is segmented into type and region.
On the basis of type, the market is fragmented into intraoperative ultrasound, intraoperative CT, intraoperative MRI, and others. The others segment dominated the market in 2021, and is expected to continue this trend during the forecast period, owing to increase in the use of intraoperative X-ray and mobile C-arm in surgical procedures.
North America accounted for a majority of the share in 2021, and is anticipated to remain dominant during the forecast period. This is attributed to advancements in technology in the medical device sector and rise in number of product approvals in the region. However, Asia-Pacific is expected to register highest CAGR of 7.4% from 2022 to 2031, owing to increase in number of surgical procedures, rise in geriatric population, and surge in prevalence of chronic diseases.
The COVID-19 outbreak is anticipated to have a negative impact on growth of the global intraoperative imaging market. During the COVID-19 pandemic period, stringent regulations were implemented by local and national governments on the delivery of products from companies. This, in turn, led to disruption in the supply chain, thus increasing the demand-supply gap. In addition, many challenges were faced by key players in manufacturing intraoperative imaging devices, thereby hampering the growth of the market. Moreover, cancellations of non-emergency surgeries during the pandemic affect the growth of intraoperative device market. According to the report published by the British Journal of Surgery, it was reported that approximately 28.4 million elected surgeries estimated to be canceled in 2020 across the globe. According to the report shared by the National Library Medicine in July 2020, after excluding emergency surgical procedures, it was estimated that about 30,000 primary and 3,000 revision knee and hip replacement arthroplasty procedures were canceled each week in the U.S. Thus, the pandemic adversely affected organ donation and organ transplantation surgeries, which, in turn, decreased the number of these surgeries. This eventually negatively impacted the intraoperative imaging market.
On the contrary, the number of surgical procedures is expected to grow gradually post the pandemic. According to the Journal of Cureus, in 2022, it was analyzed that the number of cervical spinal fusion procedures increased by 44.9% from 2020 to 2021. Thus, increase in number of surgical procedure after pandemic fostered the use of intraoperative imaging systems
Key Findings of the Study
- By type, the others segment was the highest contributor to the market in 2020.
- Region wise, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
Companies Mentioned
- General Electric Company
- Medtronic, Inc.
- Koninklijke Philips N.V.
- Siemens Healthineers AG
- Stryker Corporation
- Fujifilm Holdings
- Carestream Health
- Carl Zeiss Meditec AG
- Brainlab AG
- Ziehm Imaging Gmbh
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 153 |
| Published | June 2022 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 2039.1 million |
| Forecasted Market Value ( USD | $ 3790.7 million |
| Compound Annual Growth Rate | 6.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
